Vyas Ramanan
Venture Partner at Third Rock Ventures
Boston, Massachusetts
Overview
Work Experience
Board Observer
2024 - Current
Marea is a biotechnology firm that uses the advancements in human genetics next-generation medications for cardiometabolic illnesses.
Raised $255,418,629.00 from Alpha Wave Global, Omega Funds, Third Rock Ventures, Surveyor Capital, Sofinnova Investments, Forbion Capital Partners, Perceptive Advisors and venBio Partners.
Venture Partner
2024
Company building to advance important medicines; now with more coffee options
Principal
2020 - 2023
Helping build companies to discover new medicines. Drinking coffee now in Fenway!
R&D
2018 - 2021
Modifier-based medicines, still drinking coffee
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Raised $496,000,000.00 from Logos Capital, Frazier Life Sciences, Janus Henderson Investors and Deep Track Capital.
Senior Associate
2016 - 2018
Building biotech companies and drinking coffee
PhD Candidate, Laboratory for Multiscale Regenerative Technologies
2011 - 2016
Doctoral research: Developing suite of technologies to enable disease modeling, genomic profiling and perturbation of host-pathogen interactions in the liver, and novel gene editing-based therapies for these pathogens. PI: Sangeeta Bhatia, MD, PhD Supported by Hertz Foundation, NSF, and MIT Presidential fellowships
Research Assistant, Molecular Systems Biology Lab
2010 - 2011
PI: Dr. Ravi Radhakrishnan
Graduate Research Assistant, Polymeric Biomaterials Laboratory
2009 - 2011
PI: Dr. Jason Burdick
Research Assistant, Polymeric Biomaterials Laboratory
2008 - 2009
Summer Associate
2009 - 2009
Lux Capital is an investment firm that invests in counter-conventional, seed-stage science and technology ventures.